VGLUT3 Ablation Differentially Modulates Glutamate Receptor Densities in Mouse Brain.
Karim S IbrahimSalah El MestikawyKhaled S Abd-ElrahmanStephen S G FergusonPublished in: eNeuro (2022)
Type 3 vesicular glutamate transporter (VGLUT3) represents a unique modulator of glutamate release from both nonglutamatergic and glutamatergic varicosities within the brain. Despite its limited abundance, VGLUT3 is vital for the regulation of glutamate signaling and, therefore, modulates the activity of various brain microcircuits. However, little is known about how glutamate receptors are regulated by VGLUT3 across different brain regions. Here, we used VGLUT3 constitutive knock-out (VGLUT3 -/- ) mice and explored how VGLUT3 deletion influences total and cell surface expression of different ionotropic and metabotropic glutamate receptors. VGLUT3 deletion upregulated the overall expression of metabotropic glutamate receptors mGluR5 and mGluR2/3 in the cerebral cortex. In contrast, no change in the total expression of ionotropic NMDAR glutamate receptors were observed in the cerebral cortex of VGLUT3 -/- mice. We noted significant reduction in cell surface levels of mGluR5, NMDAR2A, NMDAR2B, as well as reductions in dopaminergic D 1 receptors and muscarinic M1 acetylcholine receptors in the hippocampus of VGLUT3 -/- mice. Furthermore, mGluR2/3 total expression and mGluR5 cell surface levels were elevated in the striatum of VGLUT3 -/- mice. Last, AMPAR subunit GluA1 was significantly upregulated throughout cortical, hippocampal, and striatal brain regions of VGLUT3 -/- mice. Together, these findings complement and further support the evidence that VGLUT3 dynamically regulates glutamate receptor densities in several brain regions. These results suggest that VGLUT3 may play an intricate role in shaping glutamatergic signaling and plasticity in several brain areas.
Keyphrases
- cell surface
- resting state
- functional connectivity
- cerebral ischemia
- poor prognosis
- white matter
- high fat diet induced
- subarachnoid hemorrhage
- magnetic resonance
- binding protein
- magnetic resonance imaging
- metabolic syndrome
- skeletal muscle
- long non coding rna
- wild type
- multiple sclerosis
- parkinson disease
- prefrontal cortex
- temporal lobe epilepsy